You’re invited to hear the latest updates from world leaders in cerebral palsy research

Back to blog6 months ago by Renee
Will overwrite featured video.
A close up of a baby sleeping on one half of the picture the other half says Impact for cerebral palsy - latest updates in global research
Will overwrite featured image.

Rob White, Chief Executive Officer of Cerebral Palsy Alliance, would like to invite you to an exclusive and free opportunity to hear the latest updates from world leaders in cerebral palsy research.

5.30 – 6.00pm
Canapés and beverages with the presenters

6.00 – 7.30pm

7.30 – 8.00pm
Canapés and beverages with the presenters


Clayton Utz Boardroom Level 15, 1 Bligh Street, Sydney NSW 2000

Register Now.  



Michael Kruer, MD

Associate Professor, Child Health, Neurology, & Genetics
University of Arizona College of Medicine Phoenix
Barrow Neurological Institute, Phoenix Children’s Hospital

Michael Kruer, MD is a pediatric movement disorders neurologist and genetics researcher at Phoenix Children’s Hospital, USA. Michael is director of the PCH Cerebral Palsy Program and principal investigator of the Neurogenetics Unit at the University of Arizona College of Medicine Phoenix. His research uses genomic discoveries to unlock the molecular basis of cerebral palsy and related disorders. He is one of the founders of the Cerebral Palsy Genomics Consortium. His work spans clinical care, genomics, molecular and cellular neurobiology.

Presentation: Environmental influences contribute substantially to cerebral palsy (CP), yet ~1/3 of children do not have an identifiable cause for their symptoms. For many such individuals, there may be a genetic basis for their CP. Collaborating with colleagues in Adelaide and at Yale, we have identified a large proportion of individuals for whom a single gene mutation may explain their condition. Although there is no single “CP gene,” our findings suggest that a mutation in one of several crucial genes controlling early neurodevelopment may lead to CP. Furthermore, many genes converge in distinct pathways that could be targeted to develop novel therapeutics.


Yana Wilson,  B AppSci(Hons) MSc MIPH​

Research Officer, Cerebral Palsy Alliance, The University of Sydney
Visiting Scientist, Garvan Institute of Medical Research

Yana Wilson joined Cerebral Palsy Alliance (CPA) in March 2016. Prior to joining CPA, Yana worked at the Garvan Institute of Medical Research investigating and validating genes involved with ageing that had been identified in large genomic studies. In her current role, Yana provides research support to the Chair of Cerebral Palsy, identifying research opportunities and support in the area of CP Genomics.

Presentation: Genomics is increasingly hailed by many as the turning point in modern medicine. Buzzwords like “genetic sequencing”, “genomics” and “big data” are everywhere in the media, but what do they really mean and how do they relate to CP? In this brief primer on the genomics revolution, Yana will provide an overview on these topics and how Cerebral Palsy Alliance and researchers in the CP Genomics community are coming together to identify and understand the genetic contribution to CP.

Register NOW